3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
4
Neoplasms
3
Breast Neoplasms
3
Papillomavirus Infections
2
Lung Neoplasms
2
Uterine Cervical Diseases
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Pulmonary Atelectasis
1
Postural Orthostatic Tachycardia Syndrome
1
Postoperative Complications
1
Pneumonia
1
Pancreatic carcinoma, familial
1
Pancreatic cancer, adult
1
Multiple Myeloma
1
Mastocytosis
1
Lung Cancer Screening
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
HIV Infections
1
Financial Stress
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cervical Cancer Screening
1
Bronchopulmonary Disease
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
27
Oxaliplatin
24
Paclitaxel
22
Fluorouracil
21
Carboplatin
18
Leucovorin
16
Cisplatin
16
Capecitabine
16
Radiotherapy
15
Nivolumab
12
Drug Therapy
12
Radiation
10
Trastuzumab
9
Surgical Procedures, Operative
9
Immunotherapy
8
Magnetic Resonance Spectroscopy
7
Esophagectomy
7
Blood Specimen Collection
7
Taxes
6
durvalumab
5
Surveys and Questionnaires
5
Specimen Handling
5
Radiotherapy, Intensity-Modulated
5
Irinotecan
5
Immune Checkpoint Inhibitors
5
Docetaxel
5
Bevacizumab
5
tislelizumab
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Mass Screening
×
1 year
×
Clear all
NCT06335966
2026-03-17
BEST-RPP
OHSU Knight Cancer Institute
Active not recruiting
110 enrolled